Endogenous interferon-γ acts directly on tumor cells in vivo to suppress growth

Journal of Surgical Research

Volumn 64, Issue 1, 1996, Pages 68-74

  Doherty, Gerard M ^a,b   Tsung, Kangla ^a   McCluskey, Brenda ^a   Norton, Jeffrey A ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; GAMMA INTERFERON;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; GROWTH INHIBITION; GROWTH RATE; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOGENICITY; IN VIVO STUDY; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0030586077     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0308     Document Type: Article

References (20)

1. 1. Farrar, M. A., and Schreiber, R. D. The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11: 571, 1993.
2. 2. Vilcek, J., and Oliveira, I. C. Recent progress in the elucidation of interferon-gamma actions: Molecular biology and biological functions. Int. Arch. Allergy Immunol. 104: 311, 1994.
3. 3. Doherty, G. M., Alexander, H. R., Merino, M. J., Venzon, D. J., and Norton, J. A. The role of endogenous interferon gamma in murine tumor growth and tumor necrosis factor alpha antitumor efficacy. Ann. Surg. Oncol. 3: 198, 1996.
4. 4. Quattrone, A., Fibbi, G., Anichini, E., Pucci, M., Zamperini, A., Capaccioli, S., and Del Rosso, M. Reversion of the invasive phenotype of transformed human fibroblasts by anti-messenger oligonucleotide inhibition of urokinase receptor gene expression. Cancer Res. 55: 90, 1995.
5. 5. Hsieh, J.-T., Luo, W., Song, W., Wang, Y., Kleinerman, D. I., Van, N. T., and Lin, S.-H. Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches. Cancer Res. 55: 109, 1995.
6. 6. Resnicoff, M., Sell, C., Rubini, M., Coppola, D., Ambrose, D., Baserga, R., and Rubin, R. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res. 54: 2218, 1994.
7. 7. Long, L., Rubin, R., Baserga, R., and Brodt, P. Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor. Cancer Res. 55: 1006, 1995.
8. 8. Hemmi, S., Peghini, P., Metzler, M., Merlin, G., Dembic, Z., and Aguet, M. Cloning of murine interferon-γ receptor cDNA: Expression in human cells mediated high-affinity binding but is not sufficient to confer sensitivity to murine interferon-γ. Proc. Natl. Acad. Sci. USA 86: 9901, 1989.
9. 9. Doherty, G. M., Lange, J. R., Alexander, H. R., Langstein, H. N., Buresh, C. M., and Norton, J. A. Evidence for interferon-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-α. J. Immunol. 149: 1666, 1992.
10. 10. Tuttle, T. M., McCrady, C. W., Inge, T. H., Salour, M., and Bear, H. D. gamma-Interferon plays a key role in T-cell-induced tumor regression. Cancer Res. 53: 833, 1993.
11. 11. Barth, R. J., Mulé, J. J., Spiess, P. J., and Rosenberg, S. A. Interferon-gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor infiltrating lymphocytes. J. Exp. Med. 173: 647, 1991.
12. 12. Dighe, A. S., Richards, E., Old, L. J., and Schreiber, R. D. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFNγ receptors. Immunity 1: 447, 1994.
13. 13. Willman, C. L., Sever, C. E., Pallavicini, M. G., Harada, H., Tanaka, N., Slovak, M. L., Yamamoto, H., Harada, K., Meeker, T. C., List, A. F., and Taniguchi, T. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 259: 968, 1993.
14. 14. Abdollahi, A., Lord, K. A., Hoffman-Liebermann, B., and Liebermann, D. A. Interferon regulatory factor 1 is a myeloid differentiation primary response gene induced by interleukin 6 and leukemia inhibitory factor: Role in growth inhibition. Cell Growth Differ. 2: 401, 1991.
15. 15. Harada, H., Kitagawa, M., Tanaka, N., Yamamoto, H., Harada, K, Ishihara, M., and Taniguchi, T. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 259: 971, 1993.
16. 16. Tanaka, N., Kawakami, T., and Taniguchi, T. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol. Cell. Biol. 13: 4531, 1993.
17. 17. Rivoltini, L., Barracchini, K. C., Viggiano, V., Kawakami, Y., Smith, A., Mixon, A., Restifo, N. P., Topalian, S. L., Simonis, T. B., Rosenberg, S. A., and Marincola, F. M. Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes. Cancer Res. 55: 3149, 1995.
18. 18. Matory, Y. L., Chen, M., Dorfman, D. M., Williams, A., Goedegebuure, P. S., and Eberlein, T. J. Antitumor activity of three mouse mammary cancer cell lines after interferon-gamma gene transfection. Surgery 118: 251, 1995.
19. 19. Steimle, V., Siegrist, C.-A., Mottet, A., Lisowska-Grospierre, B., and Mach, B. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science 265: 106, 1994.
20. 20. Chang, C.-H., and Flavell, R. A. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181: 765, 1995.